Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1Breast 1

Conditions

Breast Neoplasms 2Sleep Wake Disorders 1Memory Disorders 1Fatigue 1Depression 1Cognitive Dysfunction 1Cognition Disorders 1Anxiety Disorders 1

Interventions

Transcranial Direct Current Stimulation 4Walking 2lime 1Ultraviolet Therapy 1Tai Ji 1Sugars 1Standard of Care 1Sodium Chloride 1Silymarin 1Organization and Administration 1Methylphenidate 1Memantine 1Low-Level Light Therapy 1G(M1) Ganglioside 1Equine-Assisted Therapy 1Drug Therapy 1Donepezil 1Docosahexaenoic Acids 1Cognitive Training 1Cognitive Behavioral Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Cognitive Dysfunction × Donepezil × Breast × Clear all
NCT02822573 2023-09-13

Remember

Wake Forest University Health Sciences

Phase 3 Completed
276 enrolled 33 charts
Breast

Breast Neoplasms, Memory Disorders, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡